{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T07:52:21Z","timestamp":1794037941828,"version":"4.8.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T00:00:00Z","timestamp":1513814400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Chagas disease, caused by the parasite <jats:italic>Trypanosoma cruzi<\/jats:italic>, is endemic in Latin America. Its acute phase is associated with high parasitism, myocarditis and profound myocardial gene expression changes. A chronic phase ensues where 30% develop severe heart lesions. Mouse models of <jats:italic>T. cruzi<\/jats:italic> infection have been used to study heart damage in Chagas disease. The aim of this study was to provide an interactome between miRNAs and their targetome in Chagas heart disease by integrating gene and microRNA expression profiling data from hearts of <jats:italic>T. cruzi<\/jats:italic> infected mice. Gene expression profiling revealed enrichment in biological processes and pathways associated with immune response and metabolism. Pathways, functional and upstream regulator analysis of the intersections between predicted targets of differentially expressed microRNAs and differentially expressed mRNAs revealed enrichment in biological processes and pathways such as IFN\u03b3, TNF\u03b1, NF-kB signaling signatures, CTL-mediated apoptosis, mitochondrial dysfunction, and Nrf2-modulated antioxidative responses. We also observed enrichment in other key heart disease-related processes like myocarditis, fibrosis, hypertrophy and arrhythmia. Our correlation study suggests that miRNAs may be implicated in the pathophysiological processes taking place the hearts of acutely <jats:italic>T. cruzi-<\/jats:italic>infected mice.<\/jats:p>","DOI":"10.1038\/s41598-017-18080-9","type":"journal-article","created":{"date-parts":[[2017,12,15]],"date-time":"2017-12-15T12:01:27Z","timestamp":1513339287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Integration of miRNA and gene expression profiles suggest a role for miRNAs in the pathobiological processes of acute Trypanosoma cruzi infection"],"prefix":"10.1038","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9944-6691","authenticated-orcid":false,"given":"Ludmila Rodrigues Pinto","family":"Ferreira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederico Moraes","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Laugier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Cabantous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6844-2361","authenticated-orcid":false,"given":"Isabela Cunha","family":"Navarro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darlan","family":"da Silva C\u00e2ndido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vagner Carvalho","family":"Rigaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana Monte","family":"Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glaucia Vilar","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela Resende","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Ruivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramendra Pati","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilda","family":"Savoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Kalil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseli","family":"Lannes-Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helder","family":"Nakaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Chevillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3699-3345","authenticated-orcid":false,"given":"Edecio","family":"Cunha-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,21]]},"reference":[{"key":"18080_CR1","first-page":"431","volume":"24","author":"FJ Carod-Artal","year":"2009","unstructured":"Carod-Artal, F. J. Globalization, stroke and Chagas disease on the hundredth anniversary of its discovery. Neurologia. \n                           24, 431\u2013432 (2009).","journal-title":"Neurologia."},{"key":"18080_CR2","first-page":"0","volume":"0","author":"JR Coura","year":"2014","unstructured":"Coura, J. R., Vinas, P. A. & Junqueira, A. C. Ecoepidemiology, short history and control of Chagas disease in the endemic countries and the new challenge for non-endemic countries. Mem Inst Oswaldo Cruz. \n                           0, 0 (2014).","journal-title":"Mem Inst Oswaldo Cruz."},{"key":"18080_CR3","doi-asserted-by":"publisher","first-page":"e1498","DOI":"10.1371\/journal.pntd.0001498","volume":"6","author":"PJ Hotez","year":"2012","unstructured":"Hotez, P. J. et al. Chagas disease: \u201cthe new HIV\/AIDS of the Americas\u201d. PLoS Negl Trop Dis. \n                           6, e1498 (2012).","journal-title":"PLoS Negl Trop Dis."},{"key":"18080_CR4","doi-asserted-by":"publisher","first-page":"1190","DOI":"10.1016\/j.jacc.2015.07.024","volume":"66","author":"R Kalil-Filho","year":"2015","unstructured":"Kalil-Filho, R. Globalization of Chagas Disease Burden and New Treatment Perspectives. J Am Coll Cardiol. \n                           66, 1190\u20131192 (2015).","journal-title":"J Am Coll Cardiol."},{"key":"18080_CR5","doi-asserted-by":"publisher","first-page":"789758","DOI":"10.1155\/2013\/789758","volume":"2013","author":"JC Pinto Dias","year":"2013","unstructured":"Pinto Dias, J. C. Human chagas disease and migration in the context of globalization: some particular aspects. J Trop Med. \n                           2013, 789758 (2013).","journal-title":"J Trop Med."},{"key":"18080_CR6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1128\/IAI.67.1.308-318.1999","volume":"67","author":"CR Marinho","year":"1999","unstructured":"Marinho, C. R., D\u2019Imperio Lima, M. R., Grisotto, M. G. & Alvarez, J. M. Influence of acute-phase parasite load on pathology, parasitism, and activation of the immune system at the late chronic phase of Chagas\u2019 disease. Infect Immun. \n                           67, 308\u2013318 (1999).","journal-title":"Infect Immun."},{"key":"18080_CR7","doi-asserted-by":"publisher","first-page":"5688","DOI":"10.4049\/jimmunol.173.9.5688","volume":"173","author":"AC Oliveira","year":"2004","unstructured":"Oliveira, A. C. et al. Expression of functional TLR4 confers proinflammatory responsiveness to Trypanosoma cruzi glycoinositolphospholipids and higher resistance to infection with T. cruzi. J Immunol. \n                           173, 5688\u20135696 (2004).","journal-title":"J Immunol."},{"key":"18080_CR8","doi-asserted-by":"publisher","first-page":"e2369","DOI":"10.1371\/journal.pntd.0002369","volume":"7","author":"MS Cardoso","year":"2013","unstructured":"Cardoso, M. S. et al. Identification and functional analysis of Trypanosoma cruzi genes that encode proteins of the glycosylphosphatidylinositol biosynthetic pathway. PLoS Negl Trop Dis. \n                           7, e2369 (2013).","journal-title":"PLoS Negl Trop Dis."},{"key":"18080_CR9","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1016\/S1286-4579(02)01609-X","volume":"4","author":"C Ropert","year":"2002","unstructured":"Ropert, C. et al. Macrophage signaling by glycosylphosphatidylinositol-anchored mucin-like glycoproteins derived from Trypanosoma cruzi trypomastigotes. Microbes Infect. \n                           4, 1015\u20131025 (2002).","journal-title":"Microbes Infect."},{"key":"18080_CR10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1002\/jlb.66.4.593","volume":"66","author":"LR Ferreira","year":"1999","unstructured":"Ferreira, L. R., Silva, A. M., Michailowsky, V., Reis, L. F. & Gazzinelli, R. T. Expression of serum amyloid A3 mRNA by inflammatory macrophages exposed to membrane glycoconjugates from Trypanosoma cruzi. J Leukoc Biol. \n                           66, 593\u2013600 (1999).","journal-title":"J Leukoc Biol."},{"key":"18080_CR11","doi-asserted-by":"publisher","first-page":"e3010","DOI":"10.1371\/journal.pntd.0003010","volume":"8","author":"DV Andrade","year":"2014","unstructured":"Andrade, D. V., Gollob, K. J. & Dutra, W. O. Acute chagas disease: new global challenges for an old neglected disease. PLoS Negl Trop Dis. \n                           8, e3010 (2014).","journal-title":"PLoS Negl Trop Dis."},{"key":"18080_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.gheart.2015.08.001","volume":"10","author":"GA Mensah","year":"2015","unstructured":"Mensah, G. A., Burns, K. M., Peprah, E. K., Sampson, U. K. & Engelgau, M. M. Opportunities and challenges in chronic Chagas cardiomyopathy. Glob Heart. \n                           10, 203\u2013207 (2015).","journal-title":"Glob Heart."},{"key":"18080_CR13","first-page":"189","volume":"374","author":"JA Urbina","year":"2016","unstructured":"Urbina, J. A., Gascon, J. & Ribeiro, I. Benznidazole for Chronic Chagas\u2019 Cardiomyopathy. N Engl J Med. \n                           374, 189 (2016).","journal-title":"N Engl J Med."},{"key":"18080_CR14","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1016\/S1473-3099(15)00243-1","volume":"15","author":"JA Perez-Molina","year":"2015","unstructured":"Perez-Molina, J. A., Perez, A. M., Norman, F. F., Monge-Maillo, B. & Lopez-Velez, R. Old and new challenges in Chagas disease. Lancet Infect Dis. \n                           15, 1347\u20131356 (2015).","journal-title":"Lancet Infect Dis."},{"key":"18080_CR15","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.ijcard.2015.07.040","volume":"199","author":"SM Keating","year":"2015","unstructured":"Keating, S. M. et al. Inflammatory and cardiac biomarkers are differentially expressed in clinical stages of Chagas disease. Int J Cardiol. \n                           199, 451\u2013459 (2015).","journal-title":"Int J Cardiol."},{"key":"18080_CR16","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2459\/JCM.0000000000000045","volume":"16","author":"V Vannucchi","year":"2015","unstructured":"Vannucchi, V. et al. Chagas disease as a cause of heart failure and ventricular arrhythmias in patients long removed from endemic areas: an emerging problem in Europe. J Cardiovasc Med (Hagerstown). \n                           16, 817\u2013823 (2015).","journal-title":"J Cardiovasc Med (Hagerstown)."},{"key":"18080_CR17","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.ccep.2015.03.016","volume":"7","author":"C Healy","year":"2015","unstructured":"Healy, C. et al. Arrhythmias in chagasic cardiomyopathy. Card Electrophysiol Clin. \n                           7, 251\u2013268 (2015).","journal-title":"Card Electrophysiol Clin."},{"key":"18080_CR18","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1586\/14779072.2015.1103648","volume":"13","author":"HB Tanowitz","year":"2015","unstructured":"Tanowitz, H. B. et al. Developments in the management of Chagas cardiomyopathy. Expert Rev Cardiovasc Ther. \n                           13, 1393\u20131409 (2015).","journal-title":"Expert Rev Cardiovasc Ther."},{"key":"18080_CR19","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1006\/jaut.2001.0523","volume":"17","author":"LC Abel","year":"2001","unstructured":"Abel, L. C. et al. Chronic Chagas\u2019 disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun. \n                           17, 99\u2013107 (2001).","journal-title":"J Autoimmun."},{"key":"18080_CR20","first-page":"914326","volume":"2014","author":"LG Nogueira","year":"2014","unstructured":"Nogueira, L. G. et al. Myocardial gene expression of T-bet, GATA-3, Ror-gammat, FoxP3, and hallmark cytokines in chronic Chagas disease cardiomyopathy: an essentially unopposed TH1-type response. Mediators Inflamm. \n                           2014, 914326 (2014).","journal-title":"Mediators Inflamm."},{"key":"18080_CR21","doi-asserted-by":"publisher","first-page":"782","DOI":"10.4330\/wjc.v6.i8.782","volume":"6","author":"LR Ferreira","year":"2014","unstructured":"Ferreira, L. R. et al. Interferon-gamma and other inflammatory mediators in cardiomyocyte signaling during Chagas disease cardiomyopathy. World J Cardiol. \n                           6, 782\u2013790 (2014).","journal-title":"World J Cardiol."},{"key":"18080_CR22","doi-asserted-by":"publisher","first-page":"683230","DOI":"10.1155\/2014\/683230","volume":"2014","author":"E Cunha-Neto","year":"2014","unstructured":"Cunha-Neto, E. & Chevillard, C. Chagas disease cardiomyopathy: immunopathology and genetics. Mediators Inflamm. \n                           2014, 683230 (2014).","journal-title":"Mediators Inflamm."},{"key":"18080_CR23","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/S0002-9440(10)62976-8","volume":"167","author":"E Cunha-Neto","year":"2005","unstructured":"Cunha-Neto, E. et al. Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas\u2019 disease cardiomyopathy. Am J Pathol. \n                           167, 305\u2013313 (2005).","journal-title":"Am J Pathol."},{"key":"18080_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S0925-4439(03)00060-7","volume":"1638","author":"N Garg","year":"2003","unstructured":"Garg, N., Popov, V. L. & Papaconstantinou, J. Profiling gene transcription reveals a deficiency of mitochondrial oxidative phosphorylation in Trypanosoma cruzi-infected murine hearts: implications in chagasic myocarditis development. Biochim Biophys Acta. \n                           1638, 106\u2013120 (2003).","journal-title":"Biochim Biophys Acta."},{"key":"18080_CR25","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1007\/s00436-003-0937-z","volume":"91","author":"S Mukherjee","year":"2003","unstructured":"Mukherjee, S. et al. Microarray analysis of changes in gene expression in a murine model of chronic chagasic cardiomyopathy. Parasitol Res. \n                           91, 187\u2013196 (2003).","journal-title":"Parasitol Res."},{"key":"18080_CR26","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.4161\/cc.10.9.15487","volume":"10","author":"MB Soares","year":"2011","unstructured":"Soares, M. B. et al. Reversion of gene expression alterations in hearts of mice with chronic chagasic cardiomyopathy after transplantation of bone marrow cells. Cell Cycle. \n                           10, 1448\u20131455 (2011).","journal-title":"Cell Cycle."},{"key":"18080_CR27","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature02871","volume":"431","author":"V Ambros","year":"2004","unstructured":"Ambros, V. The functions of animal microRNAs. Nature. \n                           431, 350\u2013355 (2004).","journal-title":"Nature."},{"key":"18080_CR28","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.coph.2007.12.013","volume":"8","author":"E Scalbert","year":"2008","unstructured":"Scalbert, E. & Bril, A. Implication of microRNAs in the cardiovascular system. Curr Opin Pharmacol. \n                           8, 181\u2013188 (2008).","journal-title":"Curr Opin Pharmacol."},{"key":"18080_CR29","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/cvr\/cvn156","volume":"79","author":"C Urbich","year":"2008","unstructured":"Urbich, C., Kuehbacher, A. & Dimmeler, S. Role of microRNAs in vascular diseases, inflammation, and angiogenesis. Cardiovasc Res. \n                           79, 581\u2013588 (2008).","journal-title":"Cardiovasc Res."},{"key":"18080_CR30","doi-asserted-by":"publisher","first-page":"H528","DOI":"10.1152\/ajpheart.00181.2015","volume":"310","author":"MG Katz","year":"2016","unstructured":"Katz, M. G., Fargnoli, A. S., Kendle, A. P., Hajjar, R. J. & Bridges, C. R. The role of microRNAs in cardiac development and regenerative capacity. Am J Physiol Heart Circ Physiol. \n                           310, H528\u2013541 (2016).","journal-title":"Am J Physiol Heart Circ Physiol."},{"key":"18080_CR31","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1113\/JP270557","volume":"594","author":"T Seeger","year":"2016","unstructured":"Seeger, T. & Boon, R. A. MicroRNAs in cardiovascular ageing. J Physiol. \n                           594, 2085\u20132094 (2016).","journal-title":"J Physiol."},{"key":"18080_CR32","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1111\/eci.12475","volume":"45","author":"PK Min","year":"2015","unstructured":"Min, P. K. & Chan, S. Y. The biology of circulating microRNAs in cardiovascular disease. Eur J Clin Invest. \n                           45, 860\u2013874 (2015).","journal-title":"Eur J Clin Invest."},{"key":"18080_CR33","doi-asserted-by":"publisher","first-page":"e0003828","DOI":"10.1371\/journal.pntd.0003828","volume":"9","author":"IC Navarro","year":"2015","unstructured":"Navarro, I. C. et al. MicroRNA Transcriptome Profiling in Heart of Trypanosoma cruzi-Infected Mice: Parasitological and Cardiological Outcomes. PLoS Negl Trop Dis. \n                           9, e0003828 (2015).","journal-title":"PLoS Negl Trop Dis."},{"key":"18080_CR34","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.yjmcc.2016.03.015","volume":"94","author":"DA Chistiakov","year":"2016","unstructured":"Chistiakov, D. A., Orekhov, A. N. & Bobryshev, Y. V. Cardiac-specific miRNA in cardiogenesis, heart function, and cardiac pathology (with focus on myocardial infarction). J Mol Cell Cardiol. \n                           94, 107\u2013121 (2016).","journal-title":"J Mol Cell Cardiol."},{"key":"18080_CR35","doi-asserted-by":"publisher","first-page":"817","DOI":"10.2174\/1389450115666140627104151","volume":"15","author":"H Yu","year":"2014","unstructured":"Yu, H., Lu, Y., Li, Z. & Wang, Q. microRNA-133: expression, function and therapeutic potential in muscle diseases and cancer. Curr Drug Targets. \n                           15, 817\u2013828 (2014).","journal-title":"Curr Drug Targets."},{"key":"18080_CR36","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.15252\/embj.201387605","volume":"33","author":"N Muraoka","year":"2014","unstructured":"Muraoka, N. et al. MiR-133 promotes cardiac reprogramming by directly repressing Snai1 and silencing fibroblast signatures. Embo J. \n                           33, 1565\u20131581 (2014).","journal-title":"Embo J."},{"key":"18080_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1161\/CIRCRESAHA.115.303252","volume":"115","author":"A Castaldi","year":"2014","unstructured":"Castaldi, A. et al. MicroRNA-133 modulates the beta1-adrenergic receptor transduction cascade. Circ Res. \n                           115, 273\u2013283 (2014).","journal-title":"Circ Res."},{"key":"18080_CR38","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1582-4934.2011.01307.x","volume":"16","author":"Y Hua","year":"2012","unstructured":"Hua, Y., Zhang, Y. & Ren, J. IGF-1 deficiency resists cardiac hypertrophy and myocardial contractile dysfunction: role of microRNA-1 and microRNA-133a. J Cell Mol Med. \n                           16, 83\u201395 (2012).","journal-title":"J Cell Mol Med."},{"key":"18080_CR39","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/j.cardfail.2010.01.002","volume":"16","author":"M Satoh","year":"2010","unstructured":"Satoh, M., Minami, Y., Takahashi, Y., Tabuchi, T. & Nakamura, M. Expression of microRNA-208 is associated with adverse clinical outcomes in human dilated cardiomyopathy. J Card Fail. \n                           16, 404\u2013410 (2010).","journal-title":"J Card Fail."},{"key":"18080_CR40","doi-asserted-by":"publisher","first-page":"22274","DOI":"10.3390\/ijms141122274","volume":"14","author":"ML Pall","year":"2013","unstructured":"Pall, M. L. The NO\/ONOO-cycle as the central cause of heart failure. Int J Mol Sci. \n                           14, 22274\u201322330 (2013).","journal-title":"Int J Mol Sci."},{"key":"18080_CR41","doi-asserted-by":"publisher","first-page":"e1005954","DOI":"10.1371\/journal.ppat.1005954","volume":"12","author":"X Wan","year":"2016","unstructured":"Wan, X., Wen, J. J., Koo, S. J., Liang, L. Y. & Garg, N. J. SIRT1-PGC1alpha-NFkappaB Pathway of Oxidative and Inflammatory Stress during Trypanosoma cruzi Infection: Benefits of SIRT1-Targeted Therapy in Improving Heart Function in Chagas Disease. PLoS Pathog. \n                           12, e1005954 (2016).","journal-title":"PLoS Pathog."},{"key":"18080_CR42","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.ccr.2012.05.016","volume":"22","author":"Y Mitsuishi","year":"2012","unstructured":"Mitsuishi, Y. et al. Nrf2 redirects glucose and glutamine into anabolic pathways in metabolic reprogramming. Cancer Cell. \n                           22, 66\u201379 (2012).","journal-title":"Cancer Cell."},{"key":"18080_CR43","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/S1286-4579(00)00388-9","volume":"2","author":"A Talvani","year":"2000","unstructured":"Talvani, A. et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect. \n                           2, 851\u2013866 (2000).","journal-title":"Microbes Infect."},{"key":"18080_CR44","doi-asserted-by":"publisher","first-page":"10002","DOI":"10.1074\/jbc.275.14.10002","volume":"275","author":"A Stephanou","year":"2000","unstructured":"Stephanou, A. et al. Ischemia-induced STAT-1 expression and activation play a critical role in cardiomyocyte apoptosis. J Biol Chem. \n                           275, 10002\u201310008 (2000).","journal-title":"J Biol Chem."},{"key":"18080_CR45","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/nrcardio.2016.203","volume":"14","author":"DA Brown","year":"2017","unstructured":"Brown, D. A. et al. Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. Nat Rev Cardiol. \n                           14, 238\u2013250 (2017).","journal-title":"Nat Rev Cardiol."},{"key":"18080_CR46","doi-asserted-by":"publisher","first-page":"2080","DOI":"10.1111\/bph.12475","volume":"171","author":"N Fillmore","year":"2014","unstructured":"Fillmore, N., Mori, J. & Lopaschuk, G. D. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. Br J Pharmacol. \n                           171, 2080\u20132090 (2014).","journal-title":"Br J Pharmacol."},{"key":"18080_CR47","doi-asserted-by":"publisher","first-page":"e003855","DOI":"10.1161\/JAHA.112.003855","volume":"1","author":"X Wan","year":"2012","unstructured":"Wan, X. et al. Defects of mtDNA replication impaired mitochondrial biogenesis during Trypanosoma cruzi infection in human cardiomyocytes and chagasic patients: the role of Nrf1\/2 and antioxidant response. J Am Heart Assoc. \n                           1, e003855 (2012).","journal-title":"J Am Heart Assoc."},{"key":"18080_CR48","doi-asserted-by":"publisher","first-page":"e1205","DOI":"10.1371\/journal.pntd.0001205","volume":"5","author":"PC Teixeira","year":"2011","unstructured":"Teixeira, P. C. et al. Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy. PLoS Negl Trop Dis. \n                           5, e1205 (2011).","journal-title":"PLoS Negl Trop Dis."},{"key":"18080_CR49","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.freeradbiomed.2013.07.025","volume":"64","author":"X Cheng","year":"2013","unstructured":"Cheng, X., Ku, C. H. & Siow, R. C. Regulation of the Nrf2 antioxidant pathway by microRNAs: New players in micromanaging redox homeostasis. Free Radic Biol Med. \n                           64, 4\u201311 (2013).","journal-title":"Free Radic Biol Med."},{"key":"18080_CR50","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.1172\/JCI58525","volume":"122","author":"CN Paiva","year":"2012","unstructured":"Paiva, C. N. et al. Oxidative stress fuels Trypanosoma cruzi infection in mice. J Clin Invest. \n                           122, 2531\u20132542 (2012).","journal-title":"J Clin Invest."},{"key":"18080_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.it.2014.08.001","volume":"35","author":"MP Soares","year":"2014","unstructured":"Soares, M. P., Gozzelino, R. & Weis, S. Tissue damage control in disease tolerance. Trends Immunol. \n                           35, 483\u2013494 (2014).","journal-title":"Trends Immunol."},{"key":"18080_CR52","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1042\/BST20150054","volume":"43","author":"MP Soares","year":"2015","unstructured":"Soares, M. P. & Ribeiro, A. M. Nrf2 as a master regulator of tissue damage control and disease tolerance to infection. Biochem Soc Trans. \n                           43, 663\u2013668 (2015).","journal-title":"Biochem Soc Trans."},{"key":"18080_CR53","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI64365","volume":"123","author":"J Halkein","year":"2013","unstructured":"Halkein, J. et al. MicroRNA-146a is a therapeutic target and biomarker for peripartum cardiomyopathy. J Clin Invest. \n                           123, 2143\u20132154 (2013).","journal-title":"J Clin Invest."},{"key":"18080_CR54","first-page":"389","volume":"4","author":"Z Brener","year":"1962","unstructured":"Brener, Z. Therapeutic activity and criterion of cure on mice experimentally infected with Trypanosoma cruzi. Rev Inst Med Trop Sao Paulo. \n                           4, 389\u2013396 (1962).","journal-title":"Rev Inst Med Trop Sao Paulo."},{"key":"18080_CR55","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. \n                           43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"18080_CR56","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1093\/bioinformatics\/btn647","volume":"25","author":"A Kauffmann","year":"2009","unstructured":"Kauffmann, A., Gentleman, R. & Huber, W. ArrayQualityMetrics\u2013a bioconductor package for quality assessment of microarray data. Bioinformatics. \n                           25, 415\u2013416 (2009).","journal-title":"Bioinformatics."},{"key":"18080_CR57","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1084\/jem.194.8.1123","volume":"194","author":"S Ehrt","year":"2001","unstructured":"Ehrt, S. et al. Reprogramming of the macrophage transcriptome in response to interferon-gamma and Mycobacterium tuberculosis: signaling roles of nitric oxide synthase-2 and phagocyte oxidase. J Exp Med. \n                           194, 1123\u20131140 (2001).","journal-title":"J Exp Med."},{"key":"18080_CR58","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA \n                           102, 15545\u201315550 (2005).","journal-title":"Proc Natl Acad Sci USA"},{"key":"18080_CR59","doi-asserted-by":"publisher","first-page":"D481","DOI":"10.1093\/nar\/gkv1351","volume":"44","author":"A Fabregat","year":"2016","unstructured":"Fabregat, A. et al. The Reactome pathway Knowledgebase. Nucleic Acids Res. \n                           44, D481\u2013487 (2016).","journal-title":"Nucleic Acids Res."},{"key":"18080_CR60","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/ni.2789","volume":"15","author":"S Li","year":"2014","unstructured":"Li, S. et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. \n                           15, 195\u2013204 (2014).","journal-title":"Nat Immunol."},{"key":"18080_CR61","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. \n                           13, 2498\u20132504 (2003).","journal-title":"Genome Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18080-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18080-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:14:17Z","timestamp":1671815657000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-017-18080-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,21]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,12]]}},"alternative-id":["18080"],"URL":"https:\/\/doi.org\/10.1038\/s41598-017-18080-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,21]]},"assertion":[{"value":"18 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 December 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"17990"}}